[Skip to Content]
[Skip to Content Landing]
Views 300
Citations 0
Correction
September 30, 2019

Error in Figure

JAMA Neurol. 2019;76(11):1401. doi:10.1001/jamaneurol.2019.3371

The Original Investigation titled “Outcomes Associated With Clopidogrel-Aspirin Use in Minor Stroke or Transient Ischemic Attack: a Pooled Analysis of Clopidogrel in High-Risk Patients With Acute Non-Disabling Cerebrovascular Events (CHANCE) and Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trials,”1 published online August 19, 2019, had an error in Figure 2. The labels “major ischemic events” (for the blue line) and “major hemorrhages” (for the yellow line) were missing from Figure 2. They have been added. This article was corrected online.

References
1.
Pan  Y, Elm  JJ, Li  H,  et al.  Outcomes associated with clopidogrel-aspirin use in minor stroke or transient ischemic attack: a pooled analysis of Clopidogrel in High-Risk Patients With Acute Non-Disabling Cerebrovascular Events (CHANCE) and Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) trials  [published online August 19, 2019].  JAMA Neurol. doi:10.1001/jamaneurol.2019.2531PubMedGoogle Scholar
×